General anaesthesia C25
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: male; Age 18-70years; indication for whipple-surgery (pancreatic cancer surgery) for pancreatic cancer treatment; planned General anesthesia with or without epidural anaesthesia
Exclusion criteria
Exclusion criteria: female; incapacitated patients; dementia; psychotic disease; mental Retardation; neoadjuvant chemotherapy <3months before surgery; renal insufficiency (GFR <60ml/min); Diabetes type I or II with Need for drug therapy; autoimmune disorder (Lupus erythematodes, Sjögren Syndrome, Spondylitis alkylosans, CREST-Syndrome, sklerodermia, Morbus crohn, colitis ulcerosa, sarkoidose, goodpasture-syndrome, celiac disease, hashimoto-thyreoiditis, Morbus Basedow, autoimmune pancreatitis, multiple sklerosis, rheumatoid Arthritis); congenital immune disorders, iatrogene immune Suppression (Steroid therapy, Transplantation); blood transfusions <14days before surgery; therapy with immune modulating drugs (statines, Arginin, Coenzyme Q; Carnitin, Cyclosporin)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of perioperative, longitudinal metabolic changes on oncologic patients by quantitative analysis of metabolites (amino acids, carnitines, sugars, phospholipids, sphingolipids, fatty acids, bile acids, zytokines) via mass spectrometry using internal Standards in patients receiving General anesthesia during pancreatic cancer surgery (whipple's surgery) | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of possible anaesthesiologic factors that may influence metabolic changes. Generating further hypothesis for more detailed studies on the influence of anaesthesiologic procedures on cancer outcome. | — |
Countries
Germany
Contacts
Universitätsklinikum Heidelberg Klinik für Anästhesiologie